Results 191 to 200 of about 4,525,509 (335)

Common Preconditions for Safe Phage Therapy of <i>Pseudomonas aeruginosa</i> Infections

, 2014
В. Н. Крылов, Е. А. Плетенева, О. В. Шабурова, Maria Bourkaltseva, С. В. Крылов, Elena Chesnokova, О. А. Полыгач   +6 more
openalex   +2 more sources

In Vitro Characteristics of Phages to Guide ‘Real Life’ Phage Therapy Suitability [PDF]

, 2018
Eoghan Casey, Douwe van Sinderen, Jennifer Mahony   +2 more
openalex   +1 more source

Associations between the gut microbiota, immune cells, and different subtypes of epilepsy: A Mendelian randomization study

Epilepsia Open, EarlyView.
Abstract Objective The gut microbiota (GM) plays a role in epilepsy development via the microbiota–gut–brain axis. However, its relationship with various epilepsy subtypes and its mediating role through immune cells remain unclear. Thus, identifying the GM linked to specific epilepsy subtypes and investigating immune mechanisms to predict epilepsy risk,
Xu Zhang, Zhenlin Yang, Jingjing Guo, Yuanxin Wei, Jinzi Li   +4 more
wiley   +1 more source

Optimizing phage therapy with artificial intelligence: a perspective. [PDF]

Front Cell Infect Microbiol
Doud MB, Robertson JM, Strathdee SA.
europepmc   +1 more source

Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection [PDF]

, 2018
Stephanie M. LaVergne, Theron Hamilton, Biswajit Biswas, Monika Kumaraswamy, Robert T. Schooley, Darcy Wooten   +5 more
openalex   +1 more source

Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials

Exploration, EarlyView.
Intra‐tumoral microbiota, which is a potential component of the tumor microenvironment, has been emerging as a key participant and driving factor in cancer. This article reviews the latest progress in this field, including the microbial community within tumors and its pro‐cancer mechanisms, as well as the anti‐tumor strategies targeting intra‐tumoral ...
Yanan Niu, Junya Feng, Jie Ma, Tixian Xiao, Wei Yuan   +4 more
wiley   +1 more source

Targeted treatment of chondrosarcoma with a bacteriophage-based particle delivering a secreted tumor necrosis factor-related apoptosis-inducing ligand

Molecular Therapy: Oncology
Chondrosarcoma (CS) is a malignant cartilage-forming bone tumor that is inherently resistant to chemotherapy and radiotherapy, leaving surgery as the only treatment option.
Aitthiphon Chongchai, Kaoutar Bentayebi, Grace Chu, Wenqing Yan, Sajee Waramit, Thanyaluck Phitak, Prachya Kongtawelert, Peraphan Pothacharoen, Keittisak Suwan, Amin Hajitou   +9 more
doaj  

Efficacy of phage therapy in controlling staphylococcal biofilms: a systematic review. [PDF]

Eur J Med Res
Mobarezi Z, Esfandiari AH, Abolbashari S, Meshkat Z.   +3 more
europepmc   +1 more source

Exploring the Potential and Advancements of Circular RNA Therapeutics

Exploration, EarlyView.
Given the remarkable advantages in terms of stability, sustained expression profile, safety, wide range of druggable targets, scalable and cost‐effective manufacturing capabilities, circRNA is currently undergoing intensive investigation for various therapeutic applications such as vaccines, protein replacement, genetic disease treatment, gene therapy,
Lei Wang, Lianqing Wang, Chunbo Dong, Jialong Liu, Guoxin Cui, Shan Gao, Zhida Liu   +6 more
wiley   +1 more source

Current Applications and the Future of Phage Therapy for Periprosthetic Joint Infections. [PDF]

Antibiotics (Basel)
Abedi AO, Abedi AA, Ferry T, Citak M.
europepmc   +1 more source